| scholarly article | Q13442814 |
| P50 | author | Dirk Foell | Q90119958 |
| P2093 | author name string | Hudson H Freeze | |
| Pratima Sinha | |||
| Geetha Srikrishna | |||
| Suzanne Ostrand-Rosenberg | |||
| Chinonyerem Okoro | |||
| P2860 | cites work | RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides | Q22010236 |
| Proinflammatory activities of S100: proteins S100A8, S100A9, and S100A8/A9 induce neutrophil chemotaxis and adhesion | Q24297271 | ||
| Loss of S100A9 (MRP14) results in reduced interleukin-8-induced CD11b surface expression, a polarized microfilament system, and diminished responsiveness to chemoattractants in vitro | Q24540945 | ||
| Inflammation and cancer | Q24649640 | ||
| RAGE, carboxylated glycans and S100A8/A9 play essential roles in colitis-associated carcinogenesis | Q24658378 | ||
| Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
| Inflammation and cancer: back to Virchow? | Q28036756 | ||
| Phagocyte-specific S100 proteins: a novel group of proinflammatory molecules | Q28191271 | ||
| Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock | Q28244377 | ||
| S100A8 and S100A9 mediate endotoxin-induced cardiomyocyte dysfunction via the receptor for advanced glycation end products | Q28276090 | ||
| NF-kappaB: linking inflammation and immunity to cancer development and progression | Q29614597 | ||
| S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles | Q29620465 | ||
| A novel anionic modification of N-glycans on mammalian endothelial cells is recognized by activated neutrophils and modulates acute inflammatory responses | Q31725434 | ||
| Cluster analysis of S100 gene expression and genes correlating to psoriasin (S100A7) expression at different stages of breast cancer development | Q33226704 | ||
| Blockade of S100A8 and S100A9 suppresses neutrophil migration in response to lipopolysaccharide | Q73827858 | ||
| Absence of S100A12 in mouse: implications for RAGE-S100A12 interaction | Q79329828 | ||
| Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells | Q80274418 | ||
| Calcium-binding proteins S100A8 and S100A9 as novel diagnostic markers in human prostate cancer | Q80404832 | ||
| Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response | Q80582229 | ||
| Carboxylated glycans mediate colitis through activation of NF-kappa B | Q81322399 | ||
| The hetero-oligomeric complex of the S100A8/S100A9 protein is extremely protease resistant | Q81441207 | ||
| CD11b+/Gr-1+ immature myeloid cells mediate suppression of T cells in mice bearing tumors of IL-1beta-secreting cells | Q81598364 | ||
| Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species. | Q34287902 | ||
| A cytokine-mediated link between innate immunity, inflammation, and cancer | Q34625152 | ||
| Myeloid cell function in MRP-14 (S100A9) null mice | Q34783815 | ||
| Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells | Q35052425 | ||
| L-arginine metabolism in myeloid cells controls T-lymphocyte functions. | Q35155944 | ||
| Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression | Q35478848 | ||
| Phagocyte-specific calcium-binding S100 proteins as clinical laboratory markers of inflammation | Q35776579 | ||
| Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy | Q36108095 | ||
| Tumor immunity: a balancing act between T cell activation, macrophage activation and tumor-induced immune suppression | Q36118293 | ||
| Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression | Q36259867 | ||
| Reversion of immune tolerance in advanced malignancy: modulation of myeloid-derived suppressor cell development by blockade of stem-cell factor function | Q36384598 | ||
| Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma | Q36403544 | ||
| RAGE signaling sustains inflammation and promotes tumor development | Q36502858 | ||
| S100A8 and S100A9 in inflammation and cancer | Q36538576 | ||
| Leukocytes, inflammation, and angiogenesis in cancer: fatal attractions | Q36540110 | ||
| S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules | Q36582027 | ||
| Altered macrophage differentiation and immune dysfunction in tumor development | Q36809767 | ||
| S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway | Q37331858 | ||
| N -Glycans on the receptor for advanced glycation end products influence amphoterin binding and neurite outgrowth | Q38290193 | ||
| Gene expression profiling of ductal carcinomas in situ and invasive breast tumors | Q38351944 | ||
| S100A8 and S100A9 overexpression is associated with poor pathological parameters in invasive ductal carcinoma of the breast | Q39974430 | ||
| Chemokine-mediated rapid turnover of myeloid-derived suppressor cells in tumor-bearing mice. | Q39997114 | ||
| Tumor-infiltrating myeloid-derived suppressor cells are pleiotropic-inflamed monocytes/macrophages that bear M1- and M2-type characteristics | Q40011425 | ||
| Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity | Q40013431 | ||
| CD80 in immune suppression by mouse ovarian carcinoma-associated Gr-1+CD11b+ myeloid cells | Q40259796 | ||
| Inflammation induces myeloid-derived suppressor cells that facilitate tumor progression | Q40338318 | ||
| Gemcitabine selectively eliminates splenic Gr-1+/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity | Q40372686 | ||
| Reduction of myeloid-derived suppressor cells and induction of M1 macrophages facilitate the rejection of established metastatic disease. | Q40474320 | ||
| Inhibition of NF-kappaB in cancer cells converts inflammation- induced tumor growth mediated by TNFalpha to TRAIL-mediated tumor regression | Q40513415 | ||
| The S100 family heterodimer, MRP-8/14, binds with high affinity to heparin and heparan sulfate glycosaminoglycans on endothelial cells | Q40766569 | ||
| High level expression and dimer characterization of the S100 EF-hand proteins, migration inhibitory factor-related proteins 8 and 14. | Q41032857 | ||
| Expression and complex assembly of calcium-binding proteins MRP8 and MRP14 during differentiation of murine myelomonocytic cells | Q41588196 | ||
| The terminology issue for myeloid-derived suppressor cells | Q42425163 | ||
| IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice | Q44259082 | ||
| VEGF inhibits T-cell development and may contribute to tumor-induced immune suppression. | Q51030448 | ||
| Myeloid dendritic cell precursors generated from bone marrow suppress T cell responses via cell contact and nitric oxide production in vitro. | Q52032290 | ||
| Expression of S100 proteins in normal human tissues and common cancers using tissue microarrays: S100A6, S100A8, S100A9 and S100A11 are all overexpressed in common cancers. | Q53360582 | ||
| Immunohistochemical investigation of S100A9 expression in pulmonary adenocarcinoma: S100A9 expression is associated with tumor differentiation. | Q53399888 | ||
| Protein expression profiles in pancreatic adenocarcinoma compared with normal pancreatic tissue and tissue affected by pancreatitis as detected by two-dimensional gel electrophoresis and mass spectrometry. | Q53629351 | ||
| Reduction of established spontaneous mammary carcinoma metastases following immunotherapy with major histocompatibility complex class II and B7.1 cell-based tumor vaccines. | Q54142377 | ||
| Gr-1+CD115+ Immature Myeloid Suppressor Cells Mediate the Development of Tumor-Induced T Regulatory Cells and T-Cell Anergy in Tumor-Bearing Host | Q57054792 | ||
| Two proteins modulating transendothelial migration of leukocytes recognize novel carboxylated glycans on endothelial cells | Q73630482 | ||
| Inhibition of myeloid cell differentiation in cancer: the role of reactive oxygen species | Q73719137 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 4666-75 | |
| P577 | publication date | 2008-10-01 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells | |
| P478 | volume | 181 |
| Q39335524 | 17β-Oestradiol enhances the expansion and activation of myeloid-derived suppressor cells via signal transducer and activator of transcription (STAT)-3 signalling in human pregnancy |
| Q36413721 | A core of kinase-regulated interactomes defines the neoplastic MDSC lineage |
| Q37418671 | A novel chemoimmunomodulating property of docetaxel: suppression of myeloid-derived suppressor cells in tumor bearers. |
| Q36005402 | A pro-inflammatory role for Th22 cells in Helicobacter pylori-associated gastritis |
| Q92299091 | AMPK activation inhibits the functions of myeloid-derived suppressor cells (MDSC): impact on cancer and aging |
| Q37676894 | Activated CD11b+ CD15+ granulocytes increase in the blood of patients with uveal melanoma |
| Q39727155 | Adjuvant effects of formalin-inactivated HSV through activation of dendritic cells and inactivation of myeloid-derived suppressor cells in cancer immunotherapy |
| Q48193695 | Alarmins and immunity. |
| Q30523797 | Alarmins: awaiting a clinical response |
| Q36299452 | An expanded myeloid derived suppressor cell population does not play a role in gammaherpesvirus-exacerbated breast cancer metastases |
| Q46538900 | An interleukin-17-mediated paracrine network promotes tumor resistance to anti-angiogenic therapy |
| Q60912221 | Analysis of the Expression and Regulation of PD-1 Protein on the Surface of Myeloid-Derived Suppressor Cells (MDSCs) |
| Q35076030 | Anti-HMGB1 monoclonal antibody ameliorates immunosuppression after peripheral tissue trauma: attenuated T-lymphocyte response and increased splenic CD11b (+) Gr-1 (+) myeloid-derived suppressor cells require HMGB1. |
| Q47807019 | Anti-Jagged Immunotherapy Inhibits MDSCs and Overcomes Tumor-Induced Tolerance. |
| Q28390573 | Anti-tumor immunity: myeloid leukocytes control the immune landscape |
| Q39146030 | Arginine Metabolism in Myeloid Cells Shapes Innate and Adaptive Immunity |
| Q90410800 | Autocrine TGFβ Is a Survival Factor for Monocytes and Drives Immunosuppressive Lineage Commitment |
| Q46633572 | Beneficial Immune Effects of Myeloid-Related Proteins in Kidney Transplant Rejection. |
| Q36112558 | Biomarkers in Exhaled Breath Condensate and Serum of Chronic Obstructive Pulmonary Disease and Non-Small-Cell Lung Cancer |
| Q37448109 | Blockade of A2b adenosine receptor reduces tumor growth and immune suppression mediated by myeloid-derived suppressor cells in a mouse model of melanoma. |
| Q36204706 | CCL2 Promotes Colorectal Carcinogenesis by Enhancing Polymorphonuclear Myeloid-Derived Suppressor Cell Population and Function |
| Q34043804 | CD14(+)S100A9(+) monocytic myeloid-derived suppressor cells and their clinical relevance in non-small cell lung cancer |
| Q40180993 | CD14+CD15-HLA-DR- myeloid-derived suppressor cells impair antimicrobial responses in patients with acute-on-chronic liver failure. |
| Q36118086 | CD38-Expressing Myeloid-Derived Suppressor Cells Promote Tumor Growth in a Murine Model of Esophageal Cancer |
| Q64923980 | Calcium-Binding Proteins S100A8 and S100A9: Investigation of Their Immune Regulatory Effect in Myeloid Cells. |
| Q42694658 | Calreticulin Fragment 39-272 Promotes B16 Melanoma Malignancy through Myeloid-Derived Suppressor Cells In Vivo |
| Q37882478 | Camouflage and sabotage: tumor escape from the immune system |
| Q33567710 | Cancer and complement |
| Q26750382 | Cancer-Associated Myeloid Regulatory Cells |
| Q91923409 | Candida/Staphylococcal Polymicrobial Intra-Abdominal Infection: Pathogenesis and Perspectives for a Novel Form of Trained Innate Immunity |
| Q33890233 | Carboxylated N-glycans on RAGE promote S100A12 binding and signaling |
| Q36338435 | Characterization of iNOS(+) Neutrophil-like ring cell in tumor-bearing mice |
| Q35648172 | Characterization of the nature of granulocytic myeloid-derived suppressor cells in tumor-bearing mice |
| Q83169012 | Chemokines in health and disease |
| Q30578627 | Chemotaxis in cancer |
| Q34178620 | Chronic alcohol ingestion modulates hepatic macrophage populations and functions in mice |
| Q35345202 | Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model |
| Q35868734 | Circulating myeloid-derived suppressor cells are increased and activated in pulmonary hypertension |
| Q41110098 | Clinical perspectives on targeting of myeloid derived suppressor cells in the treatment of cancer |
| Q37777379 | Concepts and Ways to Amplify the Antitumor Immune Response |
| Q97067692 | Contribution of Aberrant Toll Like Receptor Signaling to the Pathogenesis of Myelodysplastic Syndromes |
| Q84595151 | Contribution of myeloid-derived suppressor cells to tumor-induced immune suppression, angiogenesis, invasion and metastasis |
| Q28395157 | Coordinated regulation of myeloid cells by tumours |
| Q35613040 | Critical Role of Mast Cells and Peroxisome Proliferator-Activated Receptor γ in the Induction of Myeloid-Derived Suppressor Cells by Marijuana Cannabidiol In Vivo |
| Q36983876 | Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression |
| Q37822746 | Cross-talk between tumor and myeloid cells: how to tip the balance in favor of antitumor immunity |
| Q27021956 | Cytokines in the host response to Candida vaginitis: Identifying a role for non-classical immune mediators, S100 alarmins |
| Q40983895 | Cytotoxicity of tumor antigen specific human T cells is unimpaired by arginine depletion |
| Q90318136 | DAMP-sensing receptors in sterile inflammation and inflammatory diseases |
| Q28067434 | Damage-associated molecular patterns in cancer: a double-edged sword |
| Q89838027 | Defining the emergence of myeloid-derived suppressor cells in breast cancer using single-cell transcriptomics |
| Q36188900 | Deletion of TGF-β signaling in myeloid cells enhances their anti-tumorigenic properties. |
| Q36967364 | Deregulation of apoptotic factors Bcl-xL and Bax confers apoptotic resistance to myeloid-derived suppressor cells and contributes to their persistence in cancer. |
| Q35172873 | Diabetes and cancer: Looking at the multiligand/RAGE axis. |
| Q57817490 | Diamonds in the Rough: Harnessing Tumor-Associated Myeloid Cells for Cancer Therapy |
| Q36783264 | Different faces of hepatocellular carcinoma as a health threat in 21st century |
| Q37415572 | Distinct microRNA expression profile and targeted biological pathways in functional myeloid-derived suppressor cells induced by Δ9-tetrahydrocannabinol in vivo: regulation of CCAAT/enhancer-binding protein α by microRNA-690. |
| Q35971858 | Down-regulation of S100A9 inhibits osteosarcoma cell growth through inactivating MAPK and NF-κB signaling pathways |
| Q38733117 | Dual Inhibition of MEK and PI3K/Akt Rescues Cancer Cachexia through both Tumor-Extrinsic and -Intrinsic Activities |
| Q40350208 | Early Expansion of Circulating Granulocytic Myeloid-derived Suppressor Cells Predicts Development of Nosocomial Infections in Patients with Sepsis |
| Q35512538 | Effect of TIM-3 Blockade on the Immunophenotype and Cytokine Profile of Murine Uterine NK Cells |
| Q64100339 | Effect of tumor microenvironment on pathogenesis of the head and neck squamous cell carcinoma: a systematic review |
| Q98624989 | Effects of inducing apoptosis and inhibiting proliferation of siRNA on polyadenylate-binding protein-interacting protein 1 in tongue cell carcinoma |
| Q60054227 | Efficacy of tasquinimod in men with metastatic castration-resistant prostate cancer: A meta-analysis of randomized controlled trials |
| Q47319482 | Elevated S100A8 protein expression in breast cancer cells and breast tumor stroma is prognostic of poor disease outcome |
| Q36414066 | Elevated S100A9 expression in tumor stroma functions as an early recurrence marker for early-stage oral cancer patients through increased tumor cell invasion, angiogenesis, macrophage recruitment and interleukin-6 production |
| Q46059819 | Elevated levels of proliferating and recently migrated tumor-associated macrophages confer increased aggressiveness and worse outcomes in breast cancer |
| Q37229916 | Endogenous damage-associated molecular pattern molecules at the crossroads of inflammation and cancer |
| Q39313554 | Energy metabolic pathways control the fate and function of myeloid immune cells |
| Q39103952 | Enhanced suppressive capacity of tumor-infiltrating myeloid-derived suppressor cells compared with their peripheral counterparts |
| Q35717319 | Eosinophils in glioblastoma biology |
| Q48950646 | Evaluation of Spectral Counting for Relative Quantitation of Proteoforms in Top-Down Proteomics |
| Q37624283 | Exosomes from myeloid-derived suppressor cells carry biologically active proteins |
| Q64973469 | Expansion of Granulocytic, Myeloid-Derived Suppressor Cells in Response to Ethanol-Induced Acute Liver Damage. |
| Q35887319 | Exploiting natural anti-tumor immunity for metastatic renal cell carcinoma. |
| Q36082731 | Expression of functional toll like receptor 4 in estrogen receptor/progesterone receptor-negative breast cancer |
| Q38847806 | Fish Oil Enhances T Cell Function and Tumor Infiltration and Is Correlated With a Cancer Prevention Effect in HER-2/neu But Not PyMT Transgenic Mice |
| Q37661169 | Fueling inflammation at tumor microenvironment: the role of multiligand/RAGE axis |
| Q37001259 | Functions of S100 proteins. |
| Q40032613 | GM-CSF signalling blockade and chemotherapeutic agents act in concert to inhibit the function of myeloid-derived suppressor cells in vitro |
| Q34635334 | Galectin-3 functions as an alarmin: pathogenic role for sepsis development in murine respiratory tularemia |
| Q58542370 | Gemcitabine nanoparticles promote antitumor immunity against melanoma |
| Q36558219 | Generating Peripheral Blood Derived Lymphocytes Reacting Against Autologous Primary AML Blasts |
| Q33721765 | Generation of a new therapeutic peptide that depletes myeloid-derived suppressor cells in tumor-bearing mice |
| Q58759808 | Genetic screen in myeloid cells identifies TNF-α autocrine secretion as a factor increasing MDSC suppressive activity via Nos2 up-regulation |
| Q39185449 | Glucocorticoid Induces Hepatic Steatosis by Inhibiting Activating Transcription Factor 3 (ATF3)/S100A9 Protein Signaling in Granulocytic Myeloid-derived Suppressor Cells |
| Q90320106 | Granulocytic Myeloid-Derived Suppressor Cells Promote the Stemness of Colorectal Cancer Cells through Exosomal S100A9 |
| Q45344986 | Granulocytic myeloid-derived suppressor cells are cryosensitive and their frequency does not correlate with serum concentrations of colony-stimulating factors in head and neck cancer |
| Q54964273 | HBx-induced S100A9 in NF-κB dependent manner promotes growth and metastasis of hepatocellular carcinoma cells. |
| Q34353413 | HMGB1 enhances immune suppression by facilitating the differentiation and suppressive activity of myeloid-derived suppressor cells |
| Q91700929 | Heterogeneity of Ly6G+ Ly6C+ Myeloid-Derived Suppressor Cell Infiltrates during Staphylococcus aureus Biofilm Infection |
| Q92741121 | High expression of ID1 in monocytes is strongly associated with phenotypic and functional MDSC markers in advanced melanoma |
| Q38141522 | History of myeloid-derived suppressor cells |
| Q97637463 | Human splenic polymorphonuclear myeloid-derived suppressor cells (PMN-MDSC) are strategically-located immune regulatory cells in cancer |
| Q38326104 | Hypoxia and HIF-1 increase S100A8 and S100A9 expression in prostate cancer |
| Q43179029 | IL-11 induces differentiation of myeloid-derived suppressor cells through activation of STAT3 signalling pathway |
| Q28480915 | IL-17 mediated inflammation promotes tumor growth and progression in the skin |
| Q37305013 | IL-1β, RAGE and FABP4: targeting the dynamic trio in metabolic inflammation and related pathologies |
| Q48941494 | IL-4Rα aptamer-liposome-CpG oligodeoxynucleotides suppress tumour growth by targeting the tumour microenvironment |
| Q39613201 | IRF7 regulates the development of granulocytic myeloid-derived suppressor cells through S100A9 transrepression in cancer |
| Q35028415 | Icariin and its derivative, ICT, exert anti-inflammatory, anti-tumor effects, and modulate myeloid derived suppressive cells (MDSCs) functions. |
| Q35579455 | Id1 suppresses anti-tumour immune responses and promotes tumour progression by impairing myeloid cell maturation |
| Q28256749 | Immature myeloid cells directly contribute to skin tumor development by recruiting IL-17-producing CD4+ T cells |
| Q38989773 | Immature myeloid cells in the tumor microenvironment: Implications for immunotherapy |
| Q38261210 | Immature myeloid progenitors promote disease progression in a mouse model of Barrett's-like metaplasia |
| Q38708402 | Immune responses in multiple myeloma: role of the natural immune surveillance and potential of immunotherapies |
| Q33907609 | Immune tolerance induction by integrating innate and adaptive immune regulators |
| Q58561592 | Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression |
| Q45364959 | Immunosuppressive functions of hepatic myeloid-derived suppressor cells of normal mice and in a murine model of chronic hepatitis B virus |
| Q37829504 | Immunotherapeutic modulation of the suppressive liver and tumor microenvironments |
| Q42728755 | In vivo suppressive function of myeloid-derived suppressor cells is limited to the inflammatory site |
| Q36804752 | Increased accumulation of regulatory granulocytic myeloid cells in mannose receptor C type 1-deficient mice correlates with protection in a mouse model of neurocysticercosis. |
| Q38847656 | Induction of Myeloid-Derived Suppressor Cells in Cryopyrin-Associated Periodic Syndromes. |
| Q41928923 | Induction of nuclear factor-κB responses by the S100A9 protein is Toll-like receptor-4-dependent |
| Q38951812 | Infiltrating S100A8+ myeloid cells promote metastatic spread of human breast cancer and predict poor clinical outcome |
| Q37232937 | Inflammation enhances myeloid-derived suppressor cell cross-talk by signaling through Toll-like receptor 4 |
| Q37382352 | Interferon regulatory factor-8 modulates the development of tumour-induced CD11b+Gr-1+ myeloid cells. |
| Q49553693 | Internal Affairs: Tenascin-C as a Clinically Relevant, Endogenous Driver of Innate Immunity |
| Q37672482 | Intestinal CCL11 and eosinophilic inflammation is regulated by myeloid cell-specific RelA/p65 in mice |
| Q49456387 | Janus-Faced Myeloid-Derived Suppressor Cell Exosomes for the Good and the Bad in Cancer and Autoimmune Disease |
| Q37249025 | Lack of Muc1-regulated beta-catenin stability results in aberrant expansion of CD11b+Gr1+ myeloid-derived suppressor cells from the bone marrow |
| Q37851066 | Leukocytes as paracrine regulators of metastasis and determinants of organ-specific colonization |
| Q42840029 | Location, location, location: functional and phenotypic heterogeneity between tumor-infiltrating and non-infiltrating myeloid-derived suppressor cells |
| Q64100282 | Long noncoding RNA Pvt1 regulates the immunosuppression activity of granulocytic myeloid-derived suppressor cells in tumor-bearing mice |
| Q46907178 | Lysyl Oxidase-like Protein LOXL2 Promotes Lung Metastasis of Breast Cancer |
| Q36010284 | MCAM, as a novel receptor for S100A8/A9, mediates progression of malignant melanoma through prominent activation of NF-κB and ROS formation upon ligand binding |
| Q64241048 | MDSCs: Key Criminals of Tumor Pre-metastatic Niche Formation |
| Q34328435 | MMP-8 deficiency increases TLR/RAGE ligands S100A8 and S100A9 and exacerbates lung inflammation during endotoxemia |
| Q27024795 | Mechanism of action and clinical activity of tasquinimod in castrate-resistant prostate cancer |
| Q99546960 | Mechanisms of immune suppression by myeloid-derived suppressor cells: the role of interleukin-10 as a key immunoregulatory cytokine |
| Q92794706 | Mediators of Inflammation-Driven Expansion, Trafficking, and Function of Tumor-Infiltrating MDSCs |
| Q37229481 | Metal ion acquisition in Staphylococcus aureus: overcoming nutritional immunity |
| Q34899627 | MicroRNA-155 deficiency enhances the recruitment and functions of myeloid-derived suppressor cells in tumor microenvironment and promotes solid tumor growth |
| Q29547660 | Microenvironmental regulation of metastasis |
| Q37347953 | Modulating the expression of IFN regulatory factor 8 alters the protumorigenic behavior of CD11b+Gr-1+ myeloid cells |
| Q92731408 | Modulation of Immunosuppression by Oligonucleotide-Based Molecules and Small Molecules Targeting Myeloid-Derived Suppressor Cells |
| Q37808561 | Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function |
| Q36202912 | Murine gammaherpesvirus-68 expands, but does not activate, CD11b+ gr-1+ splenocytes in vivo |
| Q33606107 | Myeloid derived suppressor cells - a new therapeutic target in the treatment of cancer |
| Q26823251 | Myeloid suppressor cells and immune modulation in lung cancer |
| Q92650141 | Myeloid-Derived Suppressor Cells Are Regulated by Estradiol and Are a Predictive Marker for IVF Outcome |
| Q38528814 | Myeloid-Derived Suppressor Cells and Therapeutic Strategies in Cancer |
| Q49493688 | Myeloid-Derived Suppressor Cells and their Potential Application in Transplantation. |
| Q89976160 | Myeloid-Derived Suppressor Cells as a Therapeutic Target for Cancer |
| Q26749373 | Myeloid-Derived Suppressor Cells in Bacterial Infections |
| Q38931895 | Myeloid-Derived Suppressor Cells in Cancers and Inflammatory Diseases: Angel or Demon? |
| Q98465646 | Myeloid-Derived Suppressor Cells in Tumors: From Mechanisms to Antigen Specificity and Microenvironmental Regulation |
| Q47651773 | Myeloid-Derived Suppressor Cells in the Tumor Microenvironment: Current Knowledge and Future Perspectives |
| Q26799126 | Myeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor Microenvironment |
| Q48293607 | Myeloid-Derived Suppressor Cells: Immune-Suppressive Cells That Impair Antitumor Immunity and Are Sculpted by Their Environment |
| Q84303859 | Myeloid-derived suppressor cell activation by combined LPS and IFN-gamma treatment impairs DC development |
| Q39104155 | Myeloid-derived suppressor cell function is reduced by Withaferin A, a potent and abundant component of Withania somnifera root extract |
| Q27000087 | Myeloid-derived suppressor cells and anti-tumor T cells: a complex relationship |
| Q35572366 | Myeloid-derived suppressor cells are implicated in regulating permissiveness for tumor metastasis during mouse gestation. |
| Q28131637 | Myeloid-derived suppressor cells as regulators of the immune system |
| Q27010234 | Myeloid-derived suppressor cells as therapeutic target in hematological malignancies |
| Q33567728 | Myeloid-derived suppressor cells down-regulate L-selectin expression on CD4+ and CD8+ T cells |
| Q35029951 | Myeloid-derived suppressor cells express the death receptor Fas and apoptose in response to T cell-expressed FasL |
| Q37172813 | Myeloid-derived suppressor cells in breast cancer |
| Q38116711 | Myeloid-derived suppressor cells in cancer: recent progress and prospects. |
| Q27014189 | Myeloid-derived suppressor cells in cancer: therapeutic, predictive, and prognostic implications |
| Q84564794 | Myeloid-derived suppressor cells in inflammation: uncovering cell subsets with enhanced immunosuppressive functions |
| Q33555717 | Myeloid-derived suppressor cells in the development of lung cancer |
| Q38005601 | Myeloid-derived suppressor cells in transplantation and cancer |
| Q41952605 | Myeloid-derived suppressor cells interact with tumors in terms of myelopoiesis, tumorigenesis and immunosuppression: thick as thieves |
| Q34903354 | Myeloid-derived suppressor cells modulate immune responses independently of NADPH oxidase in the ovarian tumor microenvironment in mice |
| Q36718300 | Myeloid-derived suppressor cells regulate growth of multiple myeloma by inhibiting T cells in bone marrow. |
| Q37863217 | Myeloid-derived suppressor cells--their role in haemato-oncological malignancies and other cancers and possible implications for therapy |
| Q38702891 | Myeloid-derived suppressor cells: Important contributors to tumor progression and metastasis. |
| Q37393000 | Myeloid-derived suppressor cells: a novel therapeutic target |
| Q36896764 | Myeloid-derived suppressor cells: general characteristics and relevance to clinical management of pancreatic cancer |
| Q24641811 | Myeloid-derived suppressor cells: linking inflammation and cancer |
| Q36996588 | Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity |
| Q37019136 | Myeloid-derived suppressor cells: natural regulators for transplant tolerance |
| Q30411008 | Myeloid-derived suppressor cells: the dark knight or the joker in viral infections? |
| Q93132566 | Nanosecond pulsed electric field inhibits malignant melanoma growth by inducing the change of systemic immunity |
| Q33570507 | Neem leaf glycoprotein prevents post-surgical sarcoma recurrence in Swiss mice by differentially regulating cytotoxic T and myeloid-derived suppressor cells |
| Q38047048 | Negative regulation of myeloid-derived suppressor cells in cancer |
| Q57096408 | Neutrophils and the S100A9 protein critically regulate granuloma formation |
| Q38665014 | Obesity alters the lung myeloid cell landscape to enhance breast cancer metastasis through IL5 and GM-CSF. |
| Q38968944 | On the origin of myeloid-derived suppressor cells. |
| Q41910192 | Origin and Functions of Tumor-Associated Myeloid Cells (TAMCs). |
| Q46897065 | Overcoming immunosuppression in the melanoma microenvironment induced by chronic inflammation |
| Q37399800 | Oxidative modifications of S100 proteins: functional regulation by redox |
| Q37588378 | Pancreatic adenocarcinoma up-regulated factor (PAUF) enhances the accumulation and functional activity of myeloid-derived suppressor cells (MDSCs) in pancreatic cancer |
| Q34566554 | Pancreatic tumors and immature immunosuppressive myeloid cells in blood and spleen: role of inhibitory co-stimulatory molecules PDL1 and CTLA4. An in vivo and in vitro study |
| Q58801110 | Paradoxical counteraction by imatinib against cell death in myeloid progenitor 32D cells expressing p210BCR-ABL |
| Q28392626 | Pathological mobilization and activities of dendritic cells in tumor-bearing hosts: challenges and opportunities for immunotherapy of cancer |
| Q92802114 | Pathological roles of MRP14 in anemia and splenomegaly during experimental visceral leishmaniasis |
| Q45886137 | Peptide inhibitors of transforming growth factor-beta enhance the efficacy of antitumor immunotherapy. |
| Q42493330 | Peptide-based systems analysis of inflammation induced myeloid-derived suppressor cells reveals diverse signaling pathways |
| Q28079046 | Phenotype, development, and biological function of myeloid-derived suppressor cells |
| Q64065547 | Phenotypic and transcriptomic characterization of canine myeloid-derived suppressor cells |
| Q36156031 | Phenotypic, morphological, and functional heterogeneity of splenic immature myeloid cells in the host response to tularemia |
| Q36711023 | Phorbol ester-induced neutrophilic inflammatory responses selectively promote metastatic spread of melanoma in a TLR4-dependent manner |
| Q38849614 | Poly (I: C) modulates the immunosuppressive activity of myeloid-derived suppressor cells in a murine model of breast cancer |
| Q34305848 | Potential serum biomarkers for glioblastoma diagnostic assessed by proteomic approaches |
| Q36943888 | Premetastatic soil and prevention of breast cancer brain metastasis |
| Q24312111 | Pro-inflammatory S100A8 and S100A9 proteins: self-assembly into multifunctional native and amyloid complexes |
| Q35093004 | Protein synthesis of the pro-inflammatory S100A8/A9 complex in plasmacytoid dendritic cells and cell surface S100A8/A9 on leukocyte subpopulations in systemic lupus erythematosus |
| Q36021093 | Proteomic analysis of stromal proteins in different stages of colorectal cancer establishes Tenascin-C as a stromal biomarker for colorectal cancer metastasis |
| Q34616787 | Proteomic pathway analysis reveals inflammation increases myeloid-derived suppressor cell resistance to apoptosis |
| Q24658378 | RAGE, carboxylated glycans and S100A8/A9 play essential roles in colitis-associated carcinogenesis |
| Q27317214 | Rapamycin Promotes Mouse 4T1 Tumor Metastasis that Can Be Reversed by a Dendritic Cell-Based Vaccine |
| Q38950436 | Receptor for Advanced Glycation End Products (RAGE) in Type 1 Diabetes Pathogenesis. |
| Q26744395 | Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards |
| Q38006616 | Regulating the suppressors: apoptosis and inflammation govern the survival of tumor-induced myeloid-derived suppressor cells (MDSC). |
| Q37248887 | Regulation of accumulation and function of myeloid derived suppressor cells in different murine models of hepatocellular carcinoma |
| Q27022125 | Regulation of tumor metastasis by myeloid-derived suppressor cells |
| Q36896567 | Review of S100A9 biology and its role in cancer |
| Q35632399 | Role of CD11b+Gr-1+ myeloid cells in AGEs-induced myocardial injury in a mice model of acute myocardial infarction. |
| Q26765942 | Role of S100 Proteins in Colorectal Carcinogenesis |
| Q40619105 | Role of Tumor Pericytes in the Recruitment of Myeloid-Derived Suppressor Cells |
| Q92538625 | Role of Tumor-Mediated Dendritic Cell Tolerization in Immune Evasion |
| Q33869556 | Role of myeloid-derived suppressor cells in amelioration of experimental autoimmune hepatitis following activation of TRPV1 receptors by cannabidiol |
| Q38332567 | Role of myeloid-derived suppressor cells in autoimmune disease |
| Q37650123 | S100 protein family in human cancer |
| Q38061123 | S100 proteins as diagnostic and prognostic markers in colorectal and hepatocellular carcinoma |
| Q35206368 | S100 proteins in cancer |
| Q95271925 | S100-Alarmins Are Essential Pilots of Postnatal Innate Immune Adaptation |
| Q34412828 | S100A8 and S100A9 Positive Cells in Colorectal Carcinoma: Clinicopathological Analysis. |
| Q39814040 | S100A8 and S100A9 are novel nuclear factor kappa B target genes during malignant progression of murine and human liver carcinogenesis. |
| Q27024450 | S100A8 and S100A9 in cardiovascular biology and disease |
| Q35649454 | S100A8 and S100A9: new insights into their roles in malignancy |
| Q52725174 | S100A8/A9 Drives Neuroinflammatory Priming and Protects against Anxiety-like Behavior after Sepsis. |
| Q34802977 | S100A8/A9 activate key genes and pathways in colon tumor progression |
| Q36640358 | S100A8/A9 is associated with estrogen receptor loss in breast cancer |
| Q90064240 | S100A8/A9 regulates CD11b expression and neutrophil recruitment during chronic tuberculosis |
| Q34150479 | S100A9 a new marker for monocytic human myeloid-derived suppressor cells. |
| Q36287418 | S100A9 expressed in ER(-)PgR(-) breast cancers induces inflammatory cytokines and is associated with an impaired overall survival |
| Q34821218 | S100B attenuates microglia activation in gliomas: possible role of STAT3 pathway |
| Q37051646 | S100B promotes glioma growth through chemoattraction of myeloid-derived macrophages |
| Q36733391 | STAT3 regulates arginase-I in myeloid-derived suppressor cells from cancer patients |
| Q99711498 | Schistosoma japonicum SjE16.7 Protein Promotes Tumor Development via the Receptor for Advanced Glycation End Products (RAGE) |
| Q59800492 | Sepsis-Induced Immunosuppression in Neonates |
| Q39012704 | Serum amyloid A3 exacerbates cancer by enhancing the suppressive capacity of myeloid-derived suppressor cells via TLR2-dependent STAT3 activation |
| Q64103178 | Serum biomarkers identification by iTRAQ and verification by MRM: S100A8/S100A9 levels predict tumor-stroma involvement and prognosis in Glioblastoma |
| Q46375692 | Serum inhibits the immunosuppressive function of myeloid-derived suppressor cells isolated from 4T1 tumor-bearing mice |
| Q38939956 | Signal transducer and activator of transcription proteins: regulators of myeloid-derived suppressor cell-mediated immunosuppression in cancer |
| Q38204175 | Signaling pathways involved in MDSC regulation |
| Q59335796 | Single-Cell Transcriptomics in Cancer Immunobiology: The Future of Precision Oncology |
| Q48047291 | Small GTPase RBJ promotes cancer progression by mobilizing MDSCs via IL-6. |
| Q90250634 | Specific Commensal Bacterium Critically Regulates Gut Microbiota Osteoimmunomodulatory Actions During Normal Postpubertal Skeletal Growth and Maturation |
| Q38015229 | Strategies for the discovery and development of therapies for metastatic breast cancer |
| Q47745185 | Strategies to Improve Vaccine Efficacy against Tuberculosis by Targeting Innate Immunity |
| Q35033957 | Sunitinib facilitates the activation and recruitment of therapeutic anti-tumor immunity in concert with specific vaccination |
| Q46064256 | Surface Glycoproteins of Exosomes Shed by Myeloid-Derived Suppressor Cells Contribute to Function |
| Q96167094 | Surgical trauma-induced immunosuppression in cancer: Recent advances and the potential therapies |
| Q33919802 | T cells contribute to tumor progression by favoring pro-tumoral properties of intra-tumoral myeloid cells in a mouse model for spontaneous melanoma |
| Q39218352 | T helper type 17 cells contribute to anti-tumour immunity and promote the recruitment of T helper type 1 cells to the tumour. |
| Q38103582 | T-cell tolerance in cancer |
| Q36809157 | TNF Neutralization Results in the Delay of Transplantable Tumor Growth and Reduced MDSC Accumulation |
| Q36357903 | TNF signaling drives myeloid-derived suppressor cell accumulation |
| Q58801821 | TNFR1 Signaling Contributes to T Cell Anergy During Sepsis |
| Q50924516 | TNFα-induced M-MDSCs promote transplant immune tolerance via nitric oxide. |
| Q47765346 | Targeting Myeloid-Derived Suppressor Cells in Cancer |
| Q39044981 | Targeting cancer-related inflammation in the era of immunotherapy |
| Q84474553 | Targeting myeloid regulatory cells in cancer by chemotherapeutic agents |
| Q30413623 | Targeting myeloid-derived suppressor cells augments antitumor activity against lung cancer |
| Q38686477 | Targeting the Receptor for Advanced Glycation Endproducts (RAGE): A Medicinal Chemistry Perspective. |
| Q38805897 | Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy |
| Q21245714 | Tasquinimod (ABR-215050), a quinoline-3-carboxamide anti-angiogenic agent, modulates the expression of thrombospondin-1 in human prostate tumors |
| Q38812152 | Tasquinimod inhibits prostate cancer growth in bone through alterations in the bone microenvironment |
| Q35071167 | Tasquinimod modulates suppressive myeloid cells and enhances cancer immunotherapies in murine models |
| Q36370409 | Tasquinimod triggers an early change in the polarization of tumor associated macrophages in the tumor microenvironment |
| Q39360781 | Tasquinimod: a novel drug in advanced prostate cancer |
| Q90056672 | The Engagement Between MDSCs and Metastases: Partners in Crime |
| Q38953395 | The Measure of DAMPs and a role for S100A8 in recruiting suppressor cells in breast cancer lung metastasis |
| Q28388630 | The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment |
| Q98735532 | The New Era of Cancer Immunotherapy: Targeting Myeloid-Derived Suppressor Cells to Overcome Immune Evasion |
| Q28076760 | The Role of Myeloid-Derived Suppressor Cells (MDSC) in Cancer Progression |
| Q38774994 | The Role of Myeloid-Derived Suppressor Cells in Viral Infection |
| Q28077740 | The Role of Toll-Like Receptors in Hematopoietic Malignancies |
| Q26799120 | The Tumor Macroenvironment: Cancer-Promoting Networks Beyond Tumor Beds |
| Q59804789 | The Yin and Yang of Myeloid Derived Suppressor Cells |
| Q36072831 | The anti-tumor effect of the quinoline-3-carboxamide tasquinimod: blockade of recruitment of CD11b(+) Ly6C(hi) cells to tumor tissue reduces tumor growth |
| Q38649547 | The immunobiology of myeloid-derived suppressor cells in cancer |
| Q58763732 | The immunomodulatory quinoline-3-carboxamide paquinimod reverses established fibrosis in a novel mouse model for liver fibrosis |
| Q33660069 | The innate and adaptive infiltrating immune systems as targets for breast cancer immunotherapy. |
| Q37507187 | The myeloid immune signature of enterotoxigenic Bacteroides fragilis-induced murine colon tumorigenesis |
| Q52764597 | The novel α-glucan YCP improves the survival rates and symptoms in septic mice by regulating myeloid-derived suppressor cells. |
| Q88738698 | The potential importance of myeloid-derived suppressor cells (MDSCs) in the pathogenesis of Alzheimer's disease |
| Q34342357 | The pre-metastatic niche: finding common ground |
| Q48367212 | The ratio of HLA-DR and VNN2+ expression on CD14+ myeloid derived suppressor cells can distinguish glioblastoma from radiation necrosis patients |
| Q37212720 | The receptor RAGE: Bridging inflammation and cancer |
| Q33709243 | The receptor for advanced glycation end products promotes pancreatic carcinogenesis and accumulation of myeloid-derived suppressor cells |
| Q38239562 | The roles of myeloid-derived suppressor cells in transplantation |
| Q41379079 | Tolerance and immune suppression in the tumor microenvironment |
| Q47123300 | Toll-like receptor 2 ligand and interferon-γ suppress anti-tumor T cell responses by enhancing the immunosuppressive activity of monocytic myeloid-derived suppressor cells |
| Q40064673 | Top-down analysis of low mass proteins in exosomes shed by murine myeloid-derived suppressor cells |
| Q54940259 | Tracking the fate of adoptively transferred myeloid-derived suppressor cells in the primary breast tumor microenvironment. |
| Q92072049 | Transcriptome Analysis Identifies Immune Markers Related to Visceral Leishmaniasis Establishment in the Experimental Model of BALB/c Mice |
| Q47553626 | Transitory presence of myeloid-derived suppressor cells in neonates is critical for control of inflammation. |
| Q57299995 | Translational Potential of Therapeutics Targeting Regulatory Myeloid Cells in Tuberculosis |
| Q38067642 | Tumor microenvironment and myeloid-derived suppressor cells |
| Q91729690 | Tumor microenvironment-derived S100A8/A9 is a novel prognostic biomarker for advanced melanoma patients and during immunotherapy with anti-PD-1 antibodies |
| Q37982937 | Tumor microenvironment: a main actor in the metastasis process. |
| Q28392873 | Tumor necrosis factor links chronic obstructive pulmonary disease and K-ras mutant lung cancer through induction of an immunosuppressive pro-tumor microenvironment |
| Q37594369 | Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation |
| Q34044797 | Tumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophages |
| Q36905043 | Tumor-induced myeloid-derived suppressor cell function is independent of IFN-γ and IL-4Rα. |
| Q35169807 | Tumor-induced myeloid-derived suppressor cells promote tumor progression through oxidative metabolism in human colorectal cancer. |
| Q37597961 | Tumor-mediated inhibition of dendritic cell differentiation is mediated by down regulation of protein kinase C beta II expression |
| Q39064350 | Tumour-activated liver stromal cells regulate myeloid-derived suppressor cells accumulation in the liver |
| Q38193589 | Tumour-induced immune suppression: role of inflammatory mediators released by myelomonocytic cells. |
| Q34163882 | Type 1 T Helper Cells Induce the Accumulation of Myeloid-Derived Suppressor Cells in the Inflamed Tgfb1 Knockout Mouse Liver |
| Q47615254 | Ubiquitin Conjugation Probed by Inflammation in Myeloid-Derived Suppressor Cell Extracellular Vesicles. |
| Q26744481 | Unraveling the Pathogenesis of MDS: The NLRP3 Inflammasome and Pyroptosis Drive the MDS Phenotype |
| Q41114263 | Visualization of Tumor-Immune Interaction - Target-Specific Imaging of S100A8/A9 Reveals Pre-Metastatic Niche Establishment |
| Q34259719 | Vitamin D analog calcipotriol suppresses the Th17 cytokine-induced proinflammatory S100 "alarmins" psoriasin (S100A7) and koebnerisin (S100A15) in psoriasis |
| Q41858851 | Yes-associated protein mediates immune reprogramming in pancreatic ductal adenocarcinoma. |
| Q35207111 | Δ9-Tetrahydrocannabinol-mediated epigenetic modifications elicit myeloid-derived suppressor cell activation via STAT3/S100A8 |
Search more.